Design
Editorial
Authors
Loading...
This letter to the editor questions the dosing strategy chosen for the PEITHO-3 trial, suggesting that a half-dose treatment strategy with a 2-hour infusion time might have stronger evidence for intermediate-high-risk pulmonary embolism.
Key points are not available for this paper at this time.
Güner et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: